Uploaded July 2022 | Updated November 2026, 4 days ago
On this episode of Journal Club, Dr. Oliver Medvedik took a look at a recent paper that explores species somatic mutation and lifespan correlation published in the journal Nature.
The researchers performed whole-genome sequencing of 208 intestinal crypts from 56 individuals to study the landscape of somatic mutation across 16 mammalian species. They found that somatic mutagenesis was dominated by seemingly endogenous mutational processes in all species, including 5-methylcytosine deamination and oxidative damage. With some differences, mutational signatures in other species resembled those described in humans, although the relative contribution of each signature varied across species.
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
LEAF / Lifespan.io is a 501(c)(3) nonprofit organization. Everything we've done thus far and everything we will do in the future is thanks to your support - please stand with us to fight the diseases of aging and increase healthy human lifespan.
► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero
► Make a one-time donation and learn about other ways to support us here: lifespan.io/support
► Learn more, and help us #CrowdsourceTheCure: lifespan.io
► Subscribe: youtube.com/user/LifespanIO
On this episode of Journal Club, Dr. Oliver Medvedik took a look at a recent paper that explores species somatic mutation and lifespan correlation published in the journal Nature.
The researchers performed whole-genome sequencing of 208 intestinal crypts from 56 individuals to study the landscape of somatic mutation across 16 mammalian species. They found that somatic mutagenesis was dominated by seemingly endogenous mutational processes in all species, including 5-methylcytosine deamination and oxidative damage. With some differences, mutational signatures in other species resembled those described in humans, although the relative contribution of each signature varied across species.
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
LEAF / Lifespan.io is a 501(c)(3) nonprofit organization. Everything we've done thus far and everything we will do in the future is thanks to your support - please stand with us to fight the diseases of aging and increase healthy human lifespan.
► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero
► Make a one-time donation and learn about other ways to support us here: lifespan.io/support
► Learn more, and help us #CrowdsourceTheCure: lifespan.io
► Subscribe: youtube.com/user/LifespanIO
![The Longevity Dividend - Why Life Extension Matters For You (Jay Olshansky)
In this enlightening talk, renowned aging expert Jay Olshansky sheds light on the field of aging science or geroscience and the concept of longevity dividend. He shares his insights on key concepts such as the law of mortality, the logic behind the longevity dividend, the Faust Longevity Bargain, and the economic benefits and validation of aging science by the FDA and Congress. He also explains the human bodys limitations for long-term use and how aging science seeks to manipulate these limitations to promote healthier and longer lives. Using the metaphor of the Faustian bargain, he delves into the trade-offs of human longevity and the cost of extending life expectancy. He outlines the concept of the red zone, an area of frailty and disability that often accompanies advanced age, and the role of aging science in compressing this zone, thereby extending our years of youthful vigor. He also discusses the role of aging as the primary risk factor for many diseases, including heart disease, cancer, and Alzheimers, and the need to address aging itself rather than individual diseases. He concludes with a discussion of the progress made with regulatory bodies such as the FDA and Congress in recognizing and supporting aging science.
[00:00:00] Introduction and overview
[00:01:23] The law of mortality according to Benjamin Gompertz
[00:03:43] The human body wasnt designed for long term use
[00:05:52] The Faustian metaphor for explaining aging science
[00:09:24] The Red Zone and slowing down the biological rate of aging
[00:11:38] The Bridge of Life and compressing the risks
[00:13:58] Logic behind the Longevity Dividend
[00:17:46] Aging is the biggest risk factor
[00:18:49] Aging as the primary risk factor for heart disease, cancer, and Alzheimers
[00:19:12] Support from the FDA and Congress
[00:20:25] The importance of telling the story of aging science
About the Speaker:
S. Jay Olshansky received his PhD in Sociology at the University of Chicago in 1984. He is currently a Professor in the School of Public Health at the University of Illinois at Chicago, Research Associate at the Center on Aging at the University of Chicago and at the London School of Hygiene and Tropical Medicine, and Chief Scientist at Lapetus Solutions, Inc. The focus of his research to date has been on estimates of the upper limits to human longevity, exploring the health and public policy implications associated with individual and population aging, forecasts of the size, survival, and age structure of the population, pursuit of the scientific means to slow aging in people (The Longevity Dividend), and global implications of the re-emergence of infectious and parasitic diseases. Dr. Olshansky is on the Board of Directors of the American Federation of Aging Research; he is the first author of The Quest for Immortality: Science at the Frontiers of Aging (Norton, 2001) and A Measured Breath of Life (2013); and co-edited Aging: The Longevity Dividend (Cold Spring Harbor Laboratory Press, 2015). In 2016, Dr. Olshansky was honored with the Donald P. Kent Award from the Gerontological Society of America, the Irving S. Wright Award from the American Federation for Aging Research, and he was named a Next Avenue Influencer in Aging.
FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
https://www.lifespan.io
https://www.facebook.com/lifespanio
https://www.instagram.com/lifespan.io/
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero: https://www.lifespan.io/hero
► Subscribe: http://www.youtube.com/user/LifespanIO
► Learn more, and help us: https://www.lifespan.io
#LongBio #Biotech #Investment #EARD The Longevity Dividend - Why Life Extension Matters For You (Jay Olshansky)](https://i.ytimg.com/vi/f0Od6OwRYgg/mqdefault.jpg)





![Become the CEO of Your Own Health - Kevin Perrott & OpenCures
In this engaging talk, Kevin Perrott, founder of OpenCures, delves into the issue of aging, charting his personal journey from robust health to decline and his subsequent interest in studying this inevitable phenomenon. Perrott critiques the current state of aging research, expressing his frustration over the slow progress despite significant financial investments and increasing societal interest. Perrott introduces an iterative process that seeks to address the issue of aging, fueled by data generated from research. In an attempt to accelerate this process, Perrott suggests creating a collaborative ecosystem of entities and individuals focused on intervention development. He calls for data generation, comprehensive research and insights, and robust intervention strategies, to transform the understanding and treatment of aging.
Perrott also speaks passionately about democratizing healthcare research. He discusses the concept of self-directed researchers and their rights to conduct research on their own health, in alignment with the pursuit of life, liberty, and happiness. He reveals the development of OpenCures, a platform that allows people to access technologies typically reserved for clinical trials and academia. Kevin takes us through the companys journey, from its physical location that provides personal biobanking and other health services, to their development of an open-source platform. He emphasizes the importance of creating a well-functioning ecosystem of related companies.
[00:00:00] Problem: Age-related Loss of Health
[00:02:56] Current Interventions and Their Limitations
[00:04:09] Desperation, Suffering, and the Need for Speed in Solutions
[00:06:05] Intervention Development Cycle, Building a Time Machine
[00:10:44] An Ecosystem for Rapid Intervention
[00:12:21] OpenCures and the right of self-research
[00:14:10] Description of OpenCures physical location and services
[00:15:09] Introduction to OpenCures platform
[00:17:34] LongevityTech.Fund Collaboration and HL.Data
[00:18:47] Strategies to Speed Intervention Development
About the Speaker:
Dr. Kevin Perrott, Ph.D. is Founder and CEO, OpenCures (https://opencures.org/), Adjunct Professor, University of Alberta, Co-Founder and Advisor, Oisin Biotechnologies, President of Global Healthspan Policy Institute, and Co-Founder and Treasurer, SENS Research Foundation.
Kevin is a successful entrepreneur and owner of the largest motorcycle and snowmobile dealership in Canada, Riverside Honda and Skidoo Sales in Edmonton, Alberta. He became a cancer survivor, an experience which clearly highlighted the deficiencies of the current health technology development paradigm where the customer has almost no input in the development of their own health solutions. Armed with the realization that nothing is more valuable than health and the time to enjoy it with those you love, Kevin resolved to put his energies towards addressing these deficiencies.
In 2003, Kevin joined Aubrey de Grey and David Gobel to form the Methuselah Foundation which offered competitive prizes for advances in longevity science. A few years later he became a co-founder with Aubrey de Grey and others of SENS Research Foundation to develop interventions able to repair or make harmless the damage that accumulates and underlies multiple age-related disorders. More recently, Kevin formed OpenCures as a for-benefit corporation helping individuals perform self-directed research, generate data, and focus the value of data on the health solutions they are interested in.
Kevin has authored and co-authored several peer-reviewed articles all focused on accelerating the science underlying the development of therapies for degenerative diseases. He is a co-founder of multiple non-profit and for-profit entities whose missions are aligned with that purpose.
Kevin has a PhD in Biomedical Engineering from University of Alberta, with work performed at the Campisi Lab of the Buck Institute studying the effects of natural compounds on senescence, as well as a BSc, Double Major, in Biology and Chemistry.
FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
https://www.lifespan.io
https://www.facebook.com/lifespanio
https://www.instagram.com/lifespan.io/
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero: https://www.lifespan.io/hero
► Subscribe: https://www.youtube.com/user/LifespanIO
► Learn more, and help us: https://www.lifespan.io
#Longevity #Data #Biohacking #OpenCures Become the CEO of Your Own Health - Kevin Perrott & OpenCures](https://i.ytimg.com/vi/goCl_xOx62E/mqdefault.jpg)



